Delivery Order SPE2DR25D1053-SPE2DR26FT641
- Not listed
- The Defense Logistics Agency awarded a $4,852.12 delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for HUMIRA (adalimumab) 40 mg/0.4 mL prefilled pens. This competitively awarded, firm fixed-price contract is a non-set-aside delivery order with an ultimate completion date of November 4, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract represents a child order under AmerisourceBergen's broader pharmaceutical supply...
- The Defense Logistics Agency awarded a $17,091.36 delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of HUMIRA (adalimumab) prefilled pens at 40 mg/0.4 mL. This is a competitively awarded, firm fixed price contract with no set-aside designation and an ultimate completion date of October 29, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary pharmaceutical distribution...
- The Defense Logistics Agency awarded a $2,785.93 delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of HUMIRA (adalimumab) Pen 40 mg/0.4 mL. This competitive award, which is classified as firm fixed price with no set-aside designation, is scheduled for completion by October 28, 2025. The point of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of HUMIRA (adalimumab) prefilled pens at 40 mg/0.4 mL. This non-competitive, firm fixed-price delivery order is valued at $116,800.12 and is due for completion by August 5, 2025. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $1,591.96 delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Humira (adalimumab) prefilled pens at 40 mg/0.4 mL. This is a firm fixed-price delivery order with no set-aside designation, performed at the contractor's location in Conshohocken, Pennsylvania, with an ultimate completion date of November 6, 2025. The award represents a single transaction under a broader pharmaceutical supply relationship supporting federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 14, 2025, for the supply of HUMIRA (Adalimumab) pen injections, 40 mg/0.4 mL, with a ceiling value of $11,020.28. This is a firm fixed price delivery order with an ultimate completion date of October 15, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency awarded a $11,604.67 firm fixed price delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Humira (adalimumab) pre-filled pens, 40 mg/0.4 mL formulation. The contract is non-set-aside and competitively awarded, with an ultimate completion date of October 20, 2025. AmerisourceBergen's Corporate Office in Conshohocken, Pennsylvania will serve as the place of performance for this delivery order, which is issued under the company's...
- The Defense Logistics Agency awarded a $36,425.77 delivery order to AmerisourceBergen Drug Corp for the supply of HUMIRA Pen 40mg/4ml (2 units) under a firm fixed price contract. This delivery order, issued on October 27, 2025, with an ultimate completion date of November 24, 2025, represents a non-competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been selected to fulfill this medical supply...
- The Defense Logistics Agency awarded a $4,843.93 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of HUMIRA (adalimumab) prefilled pens at 40 mg/0.4 mL. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 8, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. The contract represents a single delivery order...
- The Defense Logistics Agency has awarded a delivery order valued at $2,338.70 to AmerisourceBergen Drug Corp for the supply of HUMIRA (adalimumab) prefilled pens containing 40 mg/0.4 mL. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with an ultimate completion date of April 25, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order under a larger contract vehicle,...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FT641Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Humira (adalimumab) 40 mg/0.4 ml prefilled pens, with a ceiling value of $14,253.56. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively under an existing Indefinite Delivery Contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of November 6, 2025. As a child contract action, this delivery order falls under AmerisourceBergen's broader indefinite delivery vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting the Defense Health Agency and military healthcare systems worldwide. The company's extensive portfolio with the DLA encompasses a wide range of pharmaceutical products including specialty medications, biologics, vaccines, and medical supplies across multiple therapeutic domains. Humira, a leading biologic treatment for autoimmune conditions such as rheumatoid arthritis, is supplied through this delivery order to support federal healthcare requirements. AmerisourceBergen's demonstrated capability in managing large-scale pharmaceutical supply contracts and its competitive award history reflect its established position as a prime vendor in the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.3k | 11/5/25 |